Filing Details
- Accession Number:
- 0000950170-25-033994
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-05 18:47:40
- Reporting Period:
- 2025-03-05
- Filing Date:
- 2025-03-05
- Accepted Time:
- 2025-03-05 18:47:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1674930 | Fulgent Genetics Inc. | FLGT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1253820 | Paul Kim | C/O Fulgent Genetics, Inc. 4399 Santa Anita Avenue El Monte CA 91731 | Cfo And Treasurer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-03-05 | 100,000 | $15.96 | 348,282 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The shares were purchased in multiple transactions ranging from $15.48 to $16.60, inclusive. The reported price is the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.